Coronavirus vaccines sent by India reach Bhutan and the Maldives

Bhutan and Maldives on Wednesday became the first two countries to receive Covid-19 vaccines sent by India

Coronavirus, vaccine, covid, drugs, clinical trials
Representational image
Press Trust of India New Delhi
2 min read Last Updated : Jan 21 2021 | 12:14 AM IST

Bhutan and Maldives on Wednesday became the first two countries to receive COVID-19 vaccines sent by India in sync with its 'neighbourhood first' policy.

External Affairs Minister S Jaishankar shared on Twitter photos of the consignments reaching the two countries.

On Tuesday, India had said it would send COVID-19 vaccines under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday.

The supplies to Sri Lanka, Afghanistan and Mauritius will commence after confirmation of necessary regulatory clearances.

It is learnt that 1,50,000 doses of Covisheild vaccine, manufactured by the Serum Institute of India (SII), were sent to Bhutan and 1,00,000 doses reached Maldives as part of India's grant assistance.

"Indian vaccines reach Maldives, reflects our special friendship," Jaishankar tweeted along with a photograph of the consignments.

"#VaccineMaitri begins. Consignment arrives in Bhutan. Another example of #NeighbourhoodFirst," he said in another tweet.

India is one of the world's biggest drugmakers, and an increasing number of countries have already approached it for procuring coronavirus vaccines.

The Ministry of External Affairs had said on Tuesday that India would supply COVID-19 vaccines to partner countries over the coming weeks and months in a phased manner, keeping in view the domestic requirements.

India has already rolled out a massive coronavirus vaccination drive under which two vaccines, Covishield and Covaxin, are being administered to frontline health workers across the country.

While Oxford-AstraZeneca's Covishield is being manufactured by the Serum Institute, Covaxin is being produced by Bharat Biotech.

The MEA said it will be ensured that domestic manufacturers have adequate stocks to meet the country's requirements while supplying abroad.

India had earlier supplied hydroxychloroquine, Remdesivir and paracetamol tablets, as well as diagnostic kits, ventilators, masks, gloves and other medical supplies to a large number of countries to help them deal with the pandemic.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

First Published: Jan 20 2021 | 4:32 PM IST

Next Story